IL148797A0 - Metal-binding compounds and uses therefor - Google Patents
Metal-binding compounds and uses thereforInfo
- Publication number
- IL148797A0 IL148797A0 IL14879700A IL14879700A IL148797A0 IL 148797 A0 IL148797 A0 IL 148797A0 IL 14879700 A IL14879700 A IL 14879700A IL 14879700 A IL14879700 A IL 14879700A IL 148797 A0 IL148797 A0 IL 148797A0
- Authority
- IL
- Israel
- Prior art keywords
- metal
- animal
- binding compounds
- reducing
- binding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15740499P | 1999-10-01 | 1999-10-01 | |
US21107800P | 2000-06-13 | 2000-06-13 | |
PCT/US2000/026952 WO2001025265A1 (en) | 1999-10-01 | 2000-09-29 | Metal-binding compounds and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148797A0 true IL148797A0 (en) | 2002-09-12 |
Family
ID=26854102
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14879700A IL148797A0 (en) | 1999-10-01 | 2000-09-29 | Metal-binding compounds and uses therefor |
IL148797A IL148797A (en) | 1999-10-01 | 2002-03-20 | Metal-binding compounds and uses thereof |
IL202812A IL202812A0 (en) | 1999-10-01 | 2009-12-17 | Metal-binding compounds and uses therefor |
IL207923A IL207923A0 (en) | 1999-10-01 | 2010-09-01 | Metal-binding compounds and uses therefor |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL148797A IL148797A (en) | 1999-10-01 | 2002-03-20 | Metal-binding compounds and uses thereof |
IL202812A IL202812A0 (en) | 1999-10-01 | 2009-12-17 | Metal-binding compounds and uses therefor |
IL207923A IL207923A0 (en) | 1999-10-01 | 2010-09-01 | Metal-binding compounds and uses therefor |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP1220870B1 (ru) |
JP (1) | JP5349722B2 (ru) |
KR (6) | KR20100075503A (ru) |
CN (2) | CN102038932B (ru) |
AT (1) | ATE553116T1 (ru) |
AU (1) | AU770999C (ru) |
BR (1) | BR0014389A (ru) |
CA (1) | CA2385551A1 (ru) |
HK (1) | HK1157635A1 (ru) |
IL (4) | IL148797A0 (ru) |
NZ (1) | NZ518266A (ru) |
WO (1) | WO2001025265A1 (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040602A1 (en) * | 2001-04-30 | 2003-02-27 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1406 daltons |
US20020160417A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons |
AU2002348301B2 (en) * | 2001-11-20 | 2008-05-08 | Dmi Biosciences, Inc. | Methods and products for oral care |
EP1572115B1 (en) | 2002-11-27 | 2015-01-21 | Ampio Pharmaceuticals, Inc. | Treatment of diseases and conditions mediated by increased phosphorylation |
JP5265762B2 (ja) | 2008-05-13 | 2013-08-14 | ユニバーシティ・オブ・カンザス | 金属抽出ペプチド(map)タグおよび関連する方法 |
WO2013181461A2 (en) | 2012-06-01 | 2013-12-05 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
CN111909238B (zh) * | 2017-06-29 | 2022-04-08 | 安徽省农业科学院农产品加工研究所 | 一种含有Ser-Cys的高锌螯合活性锌螯合肽及其应用 |
CN113563418B (zh) * | 2021-06-22 | 2023-03-03 | 中国科学院化学研究所 | 一种原位响应ros的人工酶及其制备方法与应用 |
CN114437175B (zh) * | 2022-01-29 | 2023-09-29 | 山东第一医科大学第三附属医院(山东省医学科学院附属医院) | 一种肽探针及其应用和包含该肽探针的试剂盒 |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
US4022888A (en) | 1975-09-09 | 1977-05-10 | Diagnostic Data, Inc. | Esterified orgotein |
US4461724A (en) | 1981-10-28 | 1984-07-24 | Nippon Zoki Pharmaceutical Co., Ltd. | Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treating ulcer and thrombus with them |
US4912118A (en) | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
US4760051A (en) | 1985-01-24 | 1988-07-26 | Pickart Loren R | Use of GHL-Cu as a wound-healing and anti-inflammatory agent |
US4877770A (en) | 1985-02-08 | 1989-10-31 | Procyte Corporation | Chemical derivatives of GHL-Cu |
US5348943A (en) | 1985-02-08 | 1994-09-20 | Procyte Corporation | Cosmetic and skin treatment compositions |
US5550183A (en) | 1985-02-08 | 1996-08-27 | Procyte Corporation | Metal-peptide compositions and methods for stimulating hair growth |
US5177061A (en) | 1985-02-08 | 1993-01-05 | Procyte Corporation | Method for stimulating hair growth using GHL-Cu complexes |
US4767753A (en) | 1985-02-08 | 1988-08-30 | Procyte Corporation | Methods and compositions for preventing ulcers |
US5214032A (en) | 1985-02-08 | 1993-05-25 | Procyte Corporation | GHL-CU pharmaceutical compositions and compounds |
US4810693A (en) | 1985-02-08 | 1989-03-07 | Procyte Corporation | Method for inducing biological coverings in wounds |
US4665054A (en) | 1985-02-08 | 1987-05-12 | Bioheal, Inc. | Chemical derivatives of GHL-Cu |
US5120831A (en) | 1985-02-08 | 1992-06-09 | Procyte Corporation | Metal-peptide compositions |
US5422096A (en) | 1985-05-08 | 1995-06-06 | The General Hospital Corporation | Hydroxy-aryl metal chelates for diagnostic NMR imaging |
JPS62116565A (ja) * | 1985-11-15 | 1987-05-28 | Fujisawa Pharmaceut Co Ltd | 新規ペプチド |
GB8603537D0 (en) | 1986-02-13 | 1986-03-19 | Parker D | Conjugate compound |
CA1323839C (en) | 1987-05-11 | 1993-11-02 | Loren Ralph Pickart | Methods for stimulating hair growth |
ATE110954T1 (de) | 1988-01-29 | 1994-09-15 | Peter H Proctor | Haarwachstumanregung mit nitroxyd und anderen radikalen. |
US5101041A (en) | 1989-04-26 | 1992-03-31 | The Curators Of The University Of Missouri | Triamines and their derivatives as bifunctional chelating agents |
US5460785A (en) | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
US5102990A (en) | 1989-08-09 | 1992-04-07 | Rhomed Incorporated | Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
US5443816A (en) | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
US5759515A (en) | 1989-08-09 | 1998-06-02 | Rhomed Incorporated | Polyvalent peptide pharmaceutical applications |
US5023237A (en) | 1989-08-30 | 1991-06-11 | Procyte Corporation | Methods and compositions for healing ulcers |
US5145838A (en) | 1989-08-30 | 1992-09-08 | Procyte Corporation | Methods and compositions for healing ulcers |
US5059588A (en) | 1989-10-13 | 1991-10-22 | Procyte Corporation, Incorporated | Methods and compositions for healing bone using gly his lys: copper |
US5118665A (en) | 1990-02-09 | 1992-06-02 | Procyte Corporation | Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof |
US5164367A (en) | 1990-03-26 | 1992-11-17 | Procyte Corporation | Method of using copper(ii) containing compounds to accelerate wound healing |
US5252559A (en) | 1991-08-20 | 1993-10-12 | The Procter & Gamble Company | His-Gly-Gly peptide and derivatives thereof for hair growth |
US5280038A (en) | 1992-03-13 | 1994-01-18 | Virginia Commonwealth University | Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome |
CA2094785A1 (en) | 1992-05-08 | 1993-11-09 | Jean Gariepy | Metal chelating peptide |
US5807535A (en) | 1992-07-31 | 1998-09-15 | Australian Nuclear Science & Technology Organisation | Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
US5380747A (en) | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5650134A (en) | 1993-01-12 | 1997-07-22 | Novartis Ag (Formerly Sandoz Ltd.) | Peptides |
US5464934A (en) | 1993-05-14 | 1995-11-07 | Mallinckrodt Medical, Inc. | Metal chelates as spacer compounds in biologically active peptides |
US5994339A (en) | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
US5476939A (en) | 1993-12-30 | 1995-12-19 | Abbott Laboratories | Certain pyridyl and isoquinolyl carbinolamine derivatives |
JPH07316192A (ja) | 1994-05-27 | 1995-12-05 | Hoechst Japan Ltd | L−リシル−グリシル−l−ヒスチジンおよびこれを含有する創傷治療剤 |
US5538945A (en) | 1994-06-17 | 1996-07-23 | Procyte Corporation | Stimulation of hair growth by peptide copper complexes |
US5891418A (en) | 1995-06-07 | 1999-04-06 | Rhomed Incorporated | Peptide-metal ion pharmaceutical constructs and applications |
ATE309794T1 (de) | 1995-06-26 | 2005-12-15 | Chelator Llc | Methode zur hemmung des wachstums von bakterien oder pilzen mit einem komplexbildner |
US5637311A (en) | 1995-06-29 | 1997-06-10 | Procyte Corporation | Zinc(II) complexes and methods related thereto |
RU2106146C1 (ru) | 1995-07-17 | 1998-03-10 | Институт элементоорганических соединений РАН | Средство для подавления опухолевого роста |
US5786335A (en) | 1995-11-06 | 1998-07-28 | Warner-Lambert Company | Sulfhydryl containing peptides for treating vascular disease |
US5928955A (en) | 1996-03-22 | 1999-07-27 | California Institute Of Technology | Peptidyl fluorescent chemosensor for divalent zinc |
WO1997044313A1 (en) | 1996-05-21 | 1997-11-27 | Novartis Ag | N,N'-Di(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES |
GB9613182D0 (en) | 1996-06-24 | 1996-08-28 | Nycomed Imaging As | Method |
PL184070B1 (pl) | 1996-07-30 | 2002-08-30 | Politechnika Lodzka | Sposób wytwarzania peptydów zawierających a-hydroksymetyloserynę |
US5906996A (en) | 1996-08-21 | 1999-05-25 | Murphy; Michael A. | Tetramine treatment of neurological disorders |
US5922761A (en) | 1996-09-06 | 1999-07-13 | Medinox, Inc. | Methods for in vivo reduction of iron levels and compositions useful therefor |
US5739395A (en) | 1997-01-10 | 1998-04-14 | University Of Florida Research Foundation, Inc. | Method for synthesis of rhizoferrin |
GB9711093D0 (en) | 1997-05-29 | 1997-07-23 | British Tech Group | Novel orally active iron (III) chelators |
EP1052985B1 (en) | 1998-02-04 | 2004-12-22 | University Of Florida Research Foundation, Inc. | N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and sodium salts thereof for iron chelating therapy |
DE19819843A1 (de) | 1998-05-05 | 1999-11-11 | Biotechnolog Forschung Gmbh | Metallchelat bindende Peptide |
US6348185B1 (en) | 1998-06-20 | 2002-02-19 | Washington University School Of Medicine | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
-
2000
- 2000-09-29 WO PCT/US2000/026952 patent/WO2001025265A1/en active IP Right Grant
- 2000-09-29 JP JP2001528205A patent/JP5349722B2/ja not_active Expired - Fee Related
- 2000-09-29 KR KR1020107008232A patent/KR20100075503A/ko not_active Application Discontinuation
- 2000-09-29 KR KR1020117031646A patent/KR101353140B1/ko not_active IP Right Cessation
- 2000-09-29 KR KR1020097012559A patent/KR101062041B1/ko not_active IP Right Cessation
- 2000-09-29 CN CN2010105807752A patent/CN102038932B/zh not_active Expired - Fee Related
- 2000-09-29 EP EP00967163A patent/EP1220870B1/en not_active Expired - Lifetime
- 2000-09-29 IL IL14879700A patent/IL148797A0/xx unknown
- 2000-09-29 NZ NZ518266A patent/NZ518266A/en not_active IP Right Cessation
- 2000-09-29 CA CA002385551A patent/CA2385551A1/en not_active Abandoned
- 2000-09-29 KR KR1020117006608A patent/KR20110049875A/ko not_active Application Discontinuation
- 2000-09-29 BR BR0014389-8A patent/BR0014389A/pt not_active IP Right Cessation
- 2000-09-29 KR KR1020027004228A patent/KR20020057966A/ko not_active Application Discontinuation
- 2000-09-29 KR KR1020117031645A patent/KR101312880B1/ko not_active IP Right Cessation
- 2000-09-29 AU AU77407/00A patent/AU770999C/en not_active Ceased
- 2000-09-29 CN CN00815718A patent/CN1390231A/zh active Pending
- 2000-09-29 AT AT00967163T patent/ATE553116T1/de active
- 2000-09-29 EP EP10183238A patent/EP2327713A1/en not_active Withdrawn
-
2002
- 2002-03-20 IL IL148797A patent/IL148797A/en not_active IP Right Cessation
-
2003
- 2003-05-06 HK HK11111939.8A patent/HK1157635A1/xx not_active IP Right Cessation
-
2009
- 2009-12-17 IL IL202812A patent/IL202812A0/en unknown
-
2010
- 2010-09-01 IL IL207923A patent/IL207923A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1220870A4 (en) | 2004-04-07 |
KR20100075503A (ko) | 2010-07-02 |
AU7740700A (en) | 2001-05-10 |
NZ518266A (en) | 2005-01-28 |
JP5349722B2 (ja) | 2013-11-20 |
KR101353140B1 (ko) | 2014-01-20 |
KR20120023147A (ko) | 2012-03-12 |
IL202812A0 (en) | 2011-07-31 |
AU770999C (en) | 2005-04-21 |
EP2327713A1 (en) | 2011-06-01 |
HK1157635A1 (en) | 2012-07-06 |
JP2003528814A (ja) | 2003-09-30 |
KR101312880B1 (ko) | 2013-09-30 |
ATE553116T1 (de) | 2012-04-15 |
EP1220870B1 (en) | 2012-04-11 |
CN102038932A (zh) | 2011-05-04 |
CN1390231A (zh) | 2003-01-08 |
KR20110049875A (ko) | 2011-05-12 |
IL148797A (en) | 2010-12-30 |
WO2001025265A1 (en) | 2001-04-12 |
CN102038932B (zh) | 2013-11-06 |
BR0014389A (pt) | 2002-10-29 |
CA2385551A1 (en) | 2001-04-12 |
KR20020057966A (ko) | 2002-07-12 |
KR101062041B1 (ko) | 2011-09-02 |
IL207923A0 (en) | 2011-07-31 |
KR20090086437A (ko) | 2009-08-12 |
EP1220870A1 (en) | 2002-07-10 |
AU770999B2 (en) | 2004-03-11 |
KR20120024890A (ko) | 2012-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL207923A0 (en) | Metal-binding compounds and uses therefor | |
HUP0401590A2 (hu) | Eljárások allogén sziget átültetés védelmére oldható CTLA4 mutáns molekulák alkalmazásával | |
PL297727A1 (en) | Method of isolating and purifying fatty acids and hydroxy fatty acids | |
DE60225666D1 (de) | Verfahren zur herstellung von pharmazeutischen zusammensetzungen enthaltend epothilon-analoga zur krebsbehandlung | |
PT1146896E (pt) | Formulacoes monodispersas de analogo acilado e hexamerico insulina | |
ATE282317T1 (de) | Antimikrobielle zusammensetzung zur behandlung von rindermastitis | |
UA66861C2 (ru) | 2-фенил-1-[4-(2-аминоэтокси)бензил]-индол в сочетании с эстрогенами, способы лечения и продукт для лечения | |
TW200514772A (en) | Novel tetrahydropyridine derivatives | |
ATE306925T1 (de) | Minoxidil enthaltende zubereitung | |
DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
EE200400031A (et) | Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat | |
EP1050301A4 (en) | MEDICINAL COMPOSITIONS | |
IL165259A (en) | Compounds useful in the treatment of anthrax and inhibiting lethal factor | |
DE602004031039D1 (de) | Viruzide wirkungen von einer zubereitung enthaltend cetylpyridiniumchlorid und zitronensäure | |
AU2001238332A1 (en) | Method of sterilizing articles | |
WO2002064620A3 (en) | Metal-binding compounds and uses therefor | |
DE60121459D1 (de) | Cyanidinmischung zur behandlung von dickdarmkrebs | |
EA200000762A1 (ru) | Способ для консервации органов или других тканей для трансплантации | |
HUP0301886A2 (hu) | Vivżanyag vegyi anyagok fára történż felvitelére, ilyet tartalmazó készítmény és alkalmazása | |
AU2002325825A1 (en) | Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample | |
WO2003105762A3 (en) | METHOD OF TREATING DISEASES WITH RADIUM-225 | |
ATE329613T1 (de) | Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas | |
DE60140454D1 (de) | Flüssigkeit für herzstillstand | |
GB0003225D0 (en) | Models, methods and materials relating to clinical conditions associated with reactive oxygen species | |
DE69904159T2 (de) | Zusammensetzungen zur verringerung der empfindlichkeit von dentin |